MXCT

MaxCyte Inc. Common Stock (MXCT)

Stock · NASDAQ · Health Care

$1.22as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$0.749837
Industry
Biotechnology: Commercial Physical & Biological Resarch

How MaxCyte Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$33.03MSG&A$47.04M (142%)R&D$20.82M (63%)Cost of Revenue$6.22M (19%)MXCT

Source: 10-K filed Mar 25, 2026 · via SEC EDGAR / Finnhub

MaxCyte Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • MXCT
    MaxCyte Inc. Common Stock
    $1.22
    ▼ 4.69%
    Market cap $114.62MP/E
  • ONMD
    OneMedNet Corp Class A Common Stock
    $0.5801
    ▼ 0.84%
    Market cap $43.24MP/E
    $0.49$4.22
  • ISPC
    iSpecimen Inc. Common Stock
    $1.55
    ▼ 3.44%
    Market cap $3.06MP/E
    $1.4$127.2
  • ABSI
    Absci Corporation Common Stock
    $8.72
    ▼ 7.43%
    Market cap $1.24BP/E
    $2.24$12.06
  • CRL
    Charles River Laboratories International Inc. Common Stock
    $291.74
    ▼ 1.58%
    Market cap $11.12BP/E
    $144.26$303.31
  • ICLR
    ICON plc Ordinary Shares
    $169.84
    ▲ 0.07%
    Market cap $12.13BP/E 183.55
    $66.57$203.91
  • MEDP
    Medpace Holdings Inc. Common Stock
    $599.99
    ▼ 1.89%
    Market cap $16.00BP/E 33.13
    $373$677.9

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
63.57M
Total value held
$44.65M
Institutional holders
126
Top holders this quarter
  • Unknown8.80M
  • Unknown8.20M
  • Unknown5.04M
  • Unknown3.98M
  • Unknown3.69M
  • Unknown3.37M
  • Unknown2.77M
  • Unknown2.36M
  • Unknown2.19M
  • Unknown2.19M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.